Research location
Kongsvinger
Norway
Advertisement
Research activity in Kongsvinger
NorwayCureCurrent currently publishes aggregate city-level research activity for this location: 26 trials and 26 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Kongsvinger
26 linked trials · page 1 of 1Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney DiseaseNCT02545049 · 2015-09-17 · 1 site observation
COMPLETED
A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT02236611 · 2014-09-26 · 1 site observation
COMPLETED
A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes MellitusNCT01991795 · 2014-02-10 · 1 site observation
COMPLETED
Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 DiabetesNCT01930188 · 2013-12-02 · 1 site observation
COMPLETED
The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 DiabetesNCT01836523 · 2013-11-01 · 1 site observation
COMPLETED
QVA vs. Salmeterol/Fluticasone, 52-week Exacerbation Study, FLAME (EFfect of Indacaterol Glycopyronium Vs Fluticasone Salmeterol on COPD Exacerbations)NCT01782326 · 2013-07-01 · 1 site observation
COMPLETED
Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic PatientsNCT01798706 · 2013-06-01 · 1 site observation
COMPLETED
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime InsulinNCT01713530 · 2013-02-21 · 1 site observation
COMPLETED
Patient Registry of Roflumilast In Real LifeNCT02015767 · 2013-02-01 · 1 site observation
COMPLETED
Comparison of Safety and Efficacy of the Combination Product QVA149A Against the Concurrent Administration of the Individual Components, QAB149 and NVA237, in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT01529632 · 2012-05-01 · 1 site observation
COMPLETED
Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and MetforminNCT01388361 · 2011-09-01 · 1 site observation
COMPLETED
QVA149 Versus Fluticasone/Salmeterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT01315249 · 2011-03-01 · 1 site observation
COMPLETED
BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).NCT01131676 · 2010-07-01 · 1 site observation
COMPLETED
Outpatient Treatment of Patients With Morbid Obesity - a Two-year Follow upNCT01249209 · 2010-05-01 · 1 site observation
COMPLETED
Comparison of NN1250 With Insulin Glargine in Type 1 DiabetesNCT01079234 · 2010-03-01 · 1 site observation
COMPLETED
Saxagliptin Compared to Glimepiride in Elderly Type 2 Diabetes Patients, With Inadequate Glycemic Control on MetforminNCT01006603 · 2009-10-01 · 1 site observation
COMPLETED
Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 DiabetesNCT00982644 · 2009-09-01 · 1 site observation
COMPLETED
A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD)NCT00900731 · 2009-06-01 · 1 site observation
COMPLETED
Comparison of Two NN5401 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 DiabetesNCT00614055 · 2008-01-01 · 1 site observation
COMPLETED
To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given TogetherNCT00318461 · 2006-05-01 · 1 site observation
COMPLETED
Seretide Versus Flixotide In Asthmatic Children Not Controlled By Inhaled CorticosteroidsNCT00353873 · 2005-11-18 · 1 site observation
COMPLETED
Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 DiabetesNCT00104182 · 2005-02-01 · 1 site observation
COMPLETED
GALLANT 4 Tesaglitazar vs. GlibenclamideNCT00255541 · 2004-09-01 · 1 site observation
TERMINATED
Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 DiabetesNCT01486940 · 2002-03-01 · 1 site observation
COMPLETED
Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen™ in Subjects With Type 2 DiabetesNCT01704378 · 2001-04-18 · 1 site observation
COMPLETED
Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes.NCT03220425 · 2001-02-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.